]>
IRCT20230803059017N1 IRCT 2023-08-07 Esfahan University of Medical Sciences rehabilitation methods and the use of serotonin norepinephrine reuptake inhibitors (venlafaxine) in the treatment of patients with persistent postural perceptual dizziness Comparison of vestibular rehabilitation methods and the use of serotonin norepinephrine reuptake inhibitors (venlafaxine) in the treatment of patients with persistent postural perceptual dizziness. 2023-08-23 anticipated 60 Complete https://irct.ir/trial/71834 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: First, with the help of a random number table, a number of random numbers were generated according to the sample size, and then they were placed in sealed envelopes in this order and numbered on the envelopes. Then, according to the order in which the participants entered the study, an envelope is opened and a random sequence is determined. 2-3 Persistent postural perceptual dizziness. Intervention 1: Intervention group: Treatment with venlafaxine dose 37.5 made by Hakim Pharmaceutical Company once a day for 6 weeks. Intervention 2: Intervention group: vestibular rehabilitation once weekly for 6 weeks. No - There is not a plan to make this available Justification or reason for not sharing IPD is no more information
public Niloofar Tarbiat
Hezar Jarib
Isfahan Iran (Islamic Republic of) 8174673461 +98 937 523 4838 niloofar.tarbiat@yahoo.com Esfahan University of Medical Sciences scientific Niloofar Tarbiat
Hezar Jarib
Isfahan Iran (Islamic Republic of) 8174673461 +98 937 523 4838 niloofar.tarbiat@yahoo.com Esfahan University of Medical Sciences Iran (Islamic Republic of) Comparison of two vestibular rehabilitation methods and the use of serotonin norepinephrine reuptake inhibitors (venlafaxine) in the treatment of patients with persistent postural perceptual dizziness. Age over 18 years and under 65 years Informed consent to participate in the study Dizziness Handicap Inventory (DHI) >16 18 years 65 years Both Having psychiatric and/or cognitive disorders that prevent understanding tests and questionnaires. Using drugs that cause dizziness Having brain structural disorders Having high blood pressure Having a history of heart disease such as heart failure and heart attack hyperthyroidism R42 Dizziness and giddiness Treatment - Drugs Treatment - Other Intervention group: Treatment with venlafaxine dose 37.5 made by Hakim Pharmaceutical Company once a day for 6 weeks. Intervention group: vestibular rehabilitation once weekly for 6 weeks Dizziness. Timepoint: before and after treatment (6 weeks later). Method of measurement: dizziness handicap inventory. Esfahan University of Medical Sciences Approved 2023-07-30 Ethics committee of IsfahanUniversity of Medical Sciences Hezar Jarib Isfahan Isfehan Iran (Islamic Republic of)